BioCentury
ARTICLE | Clinical News

Umecrine's UC1010 misses in premenstrual dysphoric disorder

June 12, 2014 11:32 PM UTC

The Umecrine Mood AB subsidiary of Umecrine Co. Group (Umea, Sweden) said subcutaneous UC1010 missed the primary endpoint of improving premenstrual symptom severity during the luteal phase of the mens...